Metraipolis › archive › dc_0de346fab4e6

The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382976
DOI
10.1093/abt/tbag020
License (as archived)
solo-consultazione
Archived
2026-11-03T02:41:14.856Z
SHA-256 of the archived text
b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6
Stable URL of this page
https://metraipolis.com/documento/dc_0de346fab4e6

How to cite

The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976 — Europe PMC (en), https://europepmc.org/article/MED/42382976 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0de346fab4e6 (Metraipolis archive dc_0de346fab4e6, sha256 b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6)
BibTeX
@misc{dc0de346fab4e6,
  title = {The evolving landscape of enzymatic technologies for precision synthesis of antibody-drug conjugates — Europe PMC PMID:42382976},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382976},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0de346fab4e6; sha256 b2ecb2dc5d028e29b6ba9704e3ecb0af0622bbfd70054dd70b152247e9f1c5f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382976. Agents can read the archived copy with the MCP tool read_document.